Work

Phase II experience with MDX-1106 (Ono-4538), an anti-PD-1 monoclonal antibody, in patients with selected refractory or relapsed malignancies

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.3018

Authors: J. R. Brahmer, S. L. Topalian, J. Powderly, I. Wollner, J. Picus, C. G. Drake, E. Stankevich, A. Korman, D. Pardoll, I. Lowy

Institutions: Johns Hopkins University, Henry Ford Hospital, Carolina BioOncology Institute, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2281900984

Cites:

Cited by: 22

Related to: 10